Waltz SE - Search Results

1

Glutaminase inhibition with telaglenastat (CB-839) improves treatment response in combination with ionizing radiation in head and neck squamous cell carcinoma models.

Wicker CA, Hunt BG, Krishnan S, Aziz K, Parajuli S, Palackdharry S, Elaban WR, Wise-Draper TM, Mills GB, Waltz SE, Takiar V. Wicker CA, et al. Among authors: waltz se. Cancer Lett. 2021 Apr 1;502:180-188. doi: 10.1016/j.canlet.2020.12.038. Epub 2021 Jan 12. Cancer Lett. 2021. PMID: 33450358 Free PMC article.

2

Summary and Roadmap of Breast Cancer Research in the Veterans Affairs.

Hazra A, Goldstein KM, Waltz SE, Chiba A, Colonna SV, Kelley MJ, Moss HA, Zullig LL. Hazra A, et al. Among authors: waltz se. Mil Med. 2024 Jul 9:usae345. doi: 10.1093/milmed/usae345. Online ahead of print. Mil Med. 2024. PMID: 38979894

3

Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in mice.

Meyer SE, Peace BE, Bahassi el M, Kavanaugh GM, Wagh PK, Robbins SB, Yin M, Wells SI, Zinser GM, Stambrook PJ, Waltz SE. Meyer SE, et al. Among authors: waltz se. Cancer Lett. 2010 Oct 28;296(2):186-93. doi: 10.1016/j.canlet.2010.04.011. Cancer Lett. 2010. PMID: 20434834 Free PMC article.

4

Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth.

Zhao H, Lo YH, Ma L, Waltz SE, Gray JK, Hung MC, Wang SC. Zhao H, et al. Among authors: waltz se. Mol Cancer Ther. 2011 Jan;10(1):29-36. doi: 10.1158/1535-7163.MCT-10-0778. Mol Cancer Ther. 2011. PMID: 21220489 Free PMC article.

5

Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia.

Gray JK, Paluch AM, Stuart WD, Waltz SE. Gray JK, et al. Among authors: waltz se. Cancer Lett. 2012 Jan 1;314(1):92-101. doi: 10.1016/j.canlet.2011.09.021. Epub 2011 Sep 24. Cancer Lett. 2012. PMID: 22004727 Free PMC article.

6

Maternal diethylhexyl phthalate exposure affects adiposity and insulin tolerance in offspring in a PCNA-dependent manner.

Hunt BG, Wang YL, Chen MS, Wang SC, Waltz SE. Hunt BG, et al. Among authors: waltz se. Environ Res. 2017 Nov;159:588-594. doi: 10.1016/j.envres.2017.09.004. Epub 2017 Sep 12. Environ Res. 2017. PMID: 28915506 Free PMC article.

7

MST1R (RON) expression is a novel prognostic biomarker for metastatic progression in breast cancer patients.

Hunt BG, Wicker CA, Bourn JR, Lower EE, Takiar V, Waltz SE. Hunt BG, et al. Among authors: waltz se. Breast Cancer Res Treat. 2020 Jun;181(3):529-540. doi: 10.1007/s10549-020-05653-y. Epub 2020 Apr 27. Breast Cancer Res Treat. 2020. PMID: 32342233 Free PMC article.

8

Prostate Epithelial RON Signaling Promotes M2 Macrophage Activation to Drive Prostate Tumor Growth and Progression.

Sullivan C, Brown NE, Vasiliauskas J, Pathrose P, Starnes SL, Waltz SE. Sullivan C, et al. Among authors: waltz se. Mol Cancer Res. 2020 Aug;18(8):1244-1254. doi: 10.1158/1541-7786.MCR-20-0060. Epub 2020 May 21. Mol Cancer Res. 2020. PMID: 32439702 Free PMC article.

9

Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling.

Bourn JR, Ruiz-Torres SJ, Hunt BG, Benight NM, Waltz SE. Bourn JR, et al. Among authors: waltz se. Cancer Lett. 2021 Apr 10;503:75-90. doi: 10.1016/j.canlet.2021.01.019. Epub 2021 Jan 27. Cancer Lett. 2021. PMID: 33508385 Free PMC article.

10

Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35.

Ruiz-Torres SJ, Bourn JR, Benight NM, Hunt BG, Lester C, Waltz SE. Ruiz-Torres SJ, et al. Among authors: waltz se. Oncogene. 2022 Jan;41(3):321-333. doi: 10.1038/s41388-021-02091-y. Epub 2021 Nov 6. Oncogene. 2022. PMID: 34743208 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters